People’s Vaccine Alliance says profits inappropriate when poorer countries are struggling to get access
Three of the leading Covid vaccine manufacturers have paid out $26bn in dividends and stock buyouts to shareholders in the last year – enough to cover the cost of vaccinating the population of Africa, say campaigners.
The People’s Vaccine Alliance argues that the profits made by the companies are inappropriate when most of the world cannot get the vaccines they need, which are expensive and in short supply. Campaigners want to see the companies waive their patents and help set up factories to make affordable versions of their vaccines around the world.
